首页> 外文期刊>Leukemia and lymphoma >Localization of collagen modifying enzymes on fibroblastic reticular cells and follicular dendritic cells in non-neoplastic and neoplastic lymphoid tissues
【24h】

Localization of collagen modifying enzymes on fibroblastic reticular cells and follicular dendritic cells in non-neoplastic and neoplastic lymphoid tissues

机译:胶原修饰酶在非赘生性和赘生性淋巴组织中的成纤维细胞网状细胞和滤泡树突状细胞上的定位

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this study was to evaluate the localization of collagen modifying enzymes (CMEs) on fibroblastic reticular cells (FRCs) and follicular dendritic cells (FDCs) in non-neoplastic lymphoid tissues and various malignant lymphomas. The expression of prolyl 4-hydroxylase 1 (P4H1), lysyl hydroxylase 3 (LH3), and protein disulfide isomerase (PDI) was frequently observed on FRCs and FDCs in the germinal center (GC), except for the mantle zone. The expression of CMEs was lower in most lymphomas than in their respective postulated normal counterparts. The ratio of transglutaminase II + FRCs/CD35 + FDCs was also lower in follicular lymphomas (FL) than in other lymphomas. The mRNAs of some CMEs (P4H1, prolyl 4-hydroxylase 3, LH3, and heat shock protein 47) were confirmed in almost all lymphomas. These results indicate that lymphoma cell proliferation suppresses/decreases the number of CMEs expressing FRCs and FDCs in most lymphomas.
机译:这项研究的目的是评估胶原修饰酶(CMEs)在非肿瘤性淋巴组织和各种恶性淋巴瘤中的成纤维网状细胞(FRC)和滤泡树突状细胞(FDC)上的定位。除发膜区外,在发芽中心(GC)的FRC和FDC上经常观察到脯氨酰4-羟化酶1(P4H1),赖氨酰羟化酶3(​​LH3)和蛋白质二硫键异构酶(PDI)的表达。在大多数淋巴瘤中,CMEs的表达均低于其各自假定的正常对照。滤泡性淋巴瘤(FL)中的转谷氨酰胺酶II + FRCs / CD35 + FDC的比例也比其他淋巴瘤低。在几乎所有淋巴瘤中都证实了某些CMEs(P4H1,脯氨酰4-羟化酶3,LH3和热休克蛋白47)的mRNA。这些结果表明,在大多数淋巴瘤中,淋巴瘤细胞增殖抑制/减少了表达FRC和FDC的CME的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号